MedTrace Logo

The Cohort Study of Early Esophageal Cancer or Precancerous Lesions Treated With Endoscopic Resection

NCT03377972 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2017-12-19

No results posted yet for this study

Summary

Endoscopic Submucosal Dissection (ESD) is currently the main method of treatment of early esophageal cancer and precancerous lesions. Therefore, the investigators are looking forward to conduct a cohort study on early esophageal cancer patients undergoing endoscopic treatment collected from Zhongshan Hospital, Fudan University, comparing the WHO standard with Japanese standard of endoscopic therapy diagnosis. In addition，the investigators will collect patients' detailed informations and analyze the risk factors for metastasis and recurrence of early esophageal cancer.

Conditions

  • Early Esophageal Cancer or Precancerous Lesions Treated With Endoscopic Resection

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-12-01
Completion
2018-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03377972 on ClinicalTrials.gov